Peritoneal dialysis solution biocompatibility: definitions and evaluation strategies.
about
Mesenchymal Conversion of Mesothelial Cells Is a Key Event in the Pathophysiology of the Peritoneum during Peritoneal DialysisProteomic profiling for peritoneal dialysate: differential protein expression in diabetes mellitusHGF and BMP-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelium.The selection of peritoneal mesothelial cells is important for cell therapy to prevent peritoneal fibrosis.
P2860
Peritoneal dialysis solution biocompatibility: definitions and evaluation strategies.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Peritoneal dialysis solution biocompatibility: definitions and evaluation strategies.
@ast
Peritoneal dialysis solution biocompatibility: definitions and evaluation strategies.
@en
type
label
Peritoneal dialysis solution biocompatibility: definitions and evaluation strategies.
@ast
Peritoneal dialysis solution biocompatibility: definitions and evaluation strategies.
@en
prefLabel
Peritoneal dialysis solution biocompatibility: definitions and evaluation strategies.
@ast
Peritoneal dialysis solution biocompatibility: definitions and evaluation strategies.
@en
P1476
Peritoneal dialysis solution biocompatibility: definitions and evaluation strategies
@en
P2093
Clifford J Holmes
Dirk Faict
P356
10.1046/J.1523-1755.2003.08806.X
P577
2003-12-01T00:00:00Z